Nausea. Severe abdominal pain. Compulsive bathing. These are some of the hallmarks of cannabinoid hyperemesis syndrome, a ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

TORONTO, Nov. 11, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF ) (FSE: MLZ) (MediPharm, ...

Village Farms International Inc (VFF) reports a 20% increase in fresh produce sales and a 29% rise in Canadian cannabis net ...

Veterans are being targeted by social media ads offering access to "free" medicinal cannabis, funded by the Department of ...

An Australian research team conducted a year-long longitudinal study of medical cannabis treatments for chronic pain patients ...

Oct. 2, 2024 — Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in ... Cannabinoid CBG Reduces ...

Marlborough-based medicinal cannabis grower Puro has announced a significant distribution agreement with Australian brand ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...

Inc. (TSX: ACB) reported strong results in its fiscal Q2 2025 earnings, posting a 29% year-over-year increase in total revenue, reaching $81.1 million compared to $63.1 million in ...

In the Australian state of Victoria, a trial has commenced investigating the impacts of medicinal cannabis on driving ability ...